Comera Life Sciences Inc...

AI Score

0

Unlock

0.00
-0.00 (-100.00%)
At close: Feb 27, 2025, 3:00 PM
0.09
44900.00%
After-hours: Nov 16, 2023, 07:58 PM EST

Comera Life Sciences Cash Flow Statement

Year FY22 FY21 FY20
Net Income -18M -5.45M -2.13M
Depreciation & Amortization 93.95K 86.14K 89.75K
Stock-Based Compensation 375.79K 1.11M 101.04K
Other Working Capital 1.72M -28.95K -26.05K
Other Non-Cash Items 5.21M 79.42K 171.1K
Deferred Income Tax n/a -160.59K 1.39K
Change in Working Capital 2.55M 574.2K -41.9K
Operating Cash Flow -9.77M -3.76M -1.8M
Capital Expenditures -28.61K -142.01K -12.37K
Acquisitions n/a n/a n/a
Purchase of Investments n/a n/a -107.09M
Sales Maturities Of Investments n/a n/a n/a
Other Investing Acitivies n/a n/a n/a
Investing Cash Flow -28.61K -142.01K -12.37K
Debt Repayment n/a 750K 160.59K
Common Stock Repurchased n/a n/a n/a
Dividend Paid n/a n/a n/a
Other Financial Acitivies 4.41M 9.53M n/a
Financial Cash Flow 5.24M 10.28M 1.55M
Net Cash Flow -4.56M 6.38M -264.14K
Free Cash Flow -9.8M -3.9M -1.82M